Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors.
about
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surfaceMinimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells.A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule.Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.Early prediction of revascularisation by angiomotin-targeting positron emission tomography
P2860
Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting soluble CD146 with a ...... ival of CD146-positive tumors.
@en
type
label
Targeting soluble CD146 with a ...... ival of CD146-positive tumors.
@en
prefLabel
Targeting soluble CD146 with a ...... ival of CD146-positive tumors.
@en
P2093
P2860
P356
P1433
P1476
Targeting soluble CD146 with a ...... vival of CD146-positive tumors
@en
P2093
A Foucault-Bertaud
L Vivancos
M Blot-Chabaud
P2860
P2888
P304
P356
10.1038/ONC.2016.83
P407
P577
2016-04-11T00:00:00Z
P6179
1012686214